{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:41:07Z","timestamp":1760647267332,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e31911","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T02:51:57Z","timestamp":1716519117000},"page":"e31911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune checkpoint inhibitors and renal toxicity"],"prefix":"10.1016","volume":"10","author":[{"given":"F.","family":"Bocchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"H\u00e4fliger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e31911_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.906565","article-title":"Immunotherapy and the spectrum of kidney disease: should we individualize the treatment","volume":"9","author":"Bermejo","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2024.e31911_bib2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2215\/CJN.02340219","article-title":"AKI in patients receiving immune checkpoint inhibitors","volume":"14","author":"Perazella","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e31911_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003467","article-title":"Acute kidney injury in patients treated with immune checkpoint inhibitors","volume":"9","author":"Gupta","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.heliyon.2024.e31911_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ekir.2020.10.002","article-title":"A systematic review of immune checkpoint inhibitor-associated glomerular disease","volume":"6","author":"Kitchlu","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.heliyon.2024.e31911_bib5","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.3390\/curroncol29040234","article-title":"Cutaneous adverse events associated with immune checkpoint inhibitors: a review article","volume":"29","author":"Chen","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.heliyon.2024.e31911_bib6","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.3390\/curroncol30070498","article-title":"Molecular mechanisms of cutaneous immune-related adverse events (irAEs) induced by immune checkpoint inhibitors","volume":"30","author":"Teng","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.heliyon.2024.e31911_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s11255-022-03395-y","article-title":"Immune checkpoints inhibitors and its link to acute kidney injury and renal prognosis","volume":"55","author":"Kanbay","year":"2023","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e31911_bib8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.xkme.2021.08.008","article-title":"Immune checkpoint inhibitors and kidney toxicity: advances in diagnosis and management","volume":"3","author":"Seethapathy","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.heliyon.2024.e31911_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.574271","article-title":"The use of immune checkpoint inhibitors in oncology and the occurrence of AKI: where do we stand","volume":"11","author":"Franzin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e31911_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000520798","article-title":"Acute kidney injury induced by immune checkpoint inhibitors","volume":"8","author":"Tian","year":"2022","journal-title":"Kidney Dis."},{"key":"10.1016\/j.heliyon.2024.e31911_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells11243991","article-title":"Acute kidney injury in cancer immunotherapy recipients","volume":"11","author":"Joseph","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e31911_bib12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1681\/ASN.2019070676","article-title":"Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: a multicenter study","volume":"31","author":"Cortazar","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e31911_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/j.ackd.2021.07.006","article-title":"Immunotherapy-related acute kidney injury","volume":"28","author":"Manohar","year":"2021","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.heliyon.2024.e31911_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.34067\/KID.0000852019","article-title":"Immune checkpoint inhibitor nephrotoxicity: update 2020","volume":"1","author":"Gupta","year":"2020","journal-title":"Kidney"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31911_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002500","article-title":"Immune checkpoint inhibitors as potential triggers for ANCA vasculitis","volume":"8","author":"Aqeel","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.heliyon.2024.e31911_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/antib12010010","article-title":"Rapidly progressive pauci-immune glomerulonephritis with aberrant fibrinoid necrosis associated with atezolizumab, an immune check point inhibitor: a case report and review of literature","volume":"12","author":"Nikolopoulos","year":"2023","journal-title":"Antibodies"},{"key":"10.1016\/j.heliyon.2024.e31911_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nephro.2019.05.006","article-title":"[Immune check point inhibitor-associated renal toxicity]","volume":"16","author":"Izzedine","year":"2020","journal-title":"N\u00e9phrol. Th\u00e9rapeutique"},{"key":"10.1016\/j.heliyon.2024.e31911_bib18","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e31911_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","article-title":"Management of immunotherapy-related toxicities, version 1.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Thompson","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.heliyon.2024.e31911_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000467","article-title":"Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes","volume":"8","author":"Meraz-Mu\u00f1oz","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.heliyon.2024.e31911_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2020.12.015","article-title":"A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant","volume":"100","author":"Murakami","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.heliyon.2024.e31911_bib22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jaad.2019.07.005","article-title":"Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review","volume":"82","author":"Fisher","year":"2020","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024079428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024079428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:22:45Z","timestamp":1760646165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024079428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024079428"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31911","relation":{},"ISSN":["2405-8440"],"issn-type":[{"type":"print","value":"2405-8440"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint inhibitors and renal toxicity","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e31911"}}